The bisphosphonate zoledronic acid has antimyeloma activity in vivo by inhibition of protein prenylation. [electronic resource]
Producer: 20091130Description: 239-46 p. digitalISSN:- 1097-0215
- Animals
- Apoptosis -- drug effects
- Bone Density Conservation Agents -- pharmacology
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Diphosphonates -- pharmacology
- Disease Models, Animal
- Female
- Humans
- Imidazoles -- pharmacology
- Mice
- Mice, SCID
- Multiple Myeloma -- drug therapy
- Protein Prenylation
- Transplantation, Heterologous
- Zoledronic Acid
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.